Equities research analysts at Leerink Partnrs dropped their Q4 2024 earnings per share estimates for United Therapeutics in a ...
Leerink Partnrs dropped their FY2024 earnings per share estimates for shares of United Therapeutics in a research report ...
1d
Zacks.com on MSNStrength Seen in United Therapeutics (UTHR): Can Its 4.9% Jump Turn into More Strength?United Therapeutics (UTHR) shares soared 4.9% in the last trading session to close at $370.74. The move was backed by solid volume with far more shares changing hands than in a normal session. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results